AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Parkinson’s disease is the second most common age-related neurodegenerative disorder after Alzheimer’s disease. An estimated seven to 10 million people worldwide have Parkinson’s disease. Men are 1.5 times more likely to have Parkinson’s than women. The disease affects patients’ quality of life, making social interaction more difficult and worsening their financial condition, due to the medical expenses associated with the disease.
These are just the tip of the iceberg, as it relates to sobering stats on Parkinson's disease...
On this week's solosode of The Red Light Report, I decided to report on some hot-off-the-press research about -- you guessed it -- red light therapy and Parkinson's disease. We typically associate Parkinson's as just a disease of the brain. But what if I told you that your gut microbiome may playing a larger role in the disease via the gut-brain axis?
It turns out that most individuals with Parkinson's have the opposite desired ratio of bacteria ('good' vs. 'bad') that is seen in a healthy, vibrant gut environment. This research article, which was published in early January, uncovers the amazing potential that red light therapy, specifically near-infrared light, has on improving the ratio of 'good' bacteria to 'bad' bacteria in the gut.
This is a very exciting piece of research, as it further demonstrates the versatile healing abilities of red light therapy and just how resilient our bodies can be when given what it wants. In this case, the gut wanted some NIR light. Learn lots and enjoy!
-
Dr. Mike Belkowski Discusses the following:
Upcoming events:
To learn more about red light therapy and shop for the highest-quality red light therapy products, visit www.biolight.shop
-
Stay up-to-date on social media: